Home/Filings/4/0001209191-13-014251
4//SEC Filing

Strobel Gregory A 4

Accession 0001209191-13-014251

CIK 0001254419other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:17 PM ET

Size

28.0 KB

Accession

0001209191-13-014251

Insider Transaction Report

Form 4
Period: 2013-03-01
Strobel Gregory A
President, Revenue Cycle Mgmt
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2013-03-013,6180 total
    Exercise: $15.95Exp: 2018-03-25Common Stock (3,618 underlying)
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2013-03-0121,998158,002 total
    Exercise: $15.57Exp: 2018-03-03Common Stock (21,998 underlying)
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2013-03-052,00086,002 total
    Exercise: $11.58Exp: 2018-11-09Common Stock (2,000 underlying)
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2013-03-0111,9330 total
    Exercise: $14.74Exp: 2016-01-05Common Stock (11,933 underlying)
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2013-03-0553,000105,002 total
    Exercise: $15.57Exp: 2018-03-03Common Stock (53,000 underlying)
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2013-03-016,00088,002 total
    Exercise: $11.58Exp: 2018-11-09Common Stock (6,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-03-01+6,0646,064 total
  • Sale

    Common Stock

    2013-03-01$18.82/sh6,064$114,1240 total
  • Exercise/Conversion

    Common Stock

    2013-03-05+7,2227,222 total
  • Sale

    Common Stock

    2013-03-05$19.01/sh7,222$137,2900 total
Holdings
  • Restricted Stock

    7,914
  • Restricted Stock

    11,871
  • Stock Options (Right to Buy)

    Exercise: $22.45Exp: 2009-11-12Common Stock (50,000 underlying)
    50,000
  • Restricted Stock

    11,871
Footnotes (9)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $18.85, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.99 to $19.08, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  • [F3]The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
  • [F4]The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
  • [F5]The reporting person was granted these stock options on March 25, 2008 and are fully vested.
  • [F6]The reporting person was granted these SSARs on January 5, 2009 and are fully vested.
  • [F7]The reporting person was granted these stock-settled stock appreciation rights (SSARs) on March 3, 2011. The SSARS vest equally (over the course of 60 months) beginning on March 1, 2011 such that 100% of the SSARs will be fully vested on February 1, 2016.
  • [F8]The reporting person was granted these SSARs on November 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2011 such that 100% of the SSARs will be fully vested on October 1, 2016.
  • [F9]The reporting person was granted these stock options on November 12, 2009. The stock options vest equally (over the course of 60 months) on the first day of each month beginning on November 1, 2009, such that 100% of the options will be fully vested on October 1, 2014.

Issuer

MEDASSETS INC

CIK 0001254419

Entity typeother

Related Parties

1
  • filerCIK 0001522395

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:17 PM ET
Size
28.0 KB